Iterum Therapeutics plc — Director's Dealing 2021

Jul 28, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Iterum Therapeutics plc (ITRM)
CIK: 0001659323
Period of Report: 2021-07-25

Reporting Person: Dunne Michael W. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-07-25	Ordinary Shares	A	80000	$0.00	Acquired	336355	Direct

Footnotes

F1: Consists of 80,000 ordinary shares received upon vesting of performance-based stock units ("PSUs") on July 25, 2021, which PSUs were subject to performance conditions that have been satisfied. PSUs convert into ordinary shares on a one-for-one basis.